Contineum Therapeutics Inc. has granted a non-qualified stock option to purchase 23,000 shares of Class A common stock to a new non-executive employee. The stock option vests over four years, with 25% vesting on the one-year anniversary of the vesting commencement date and the remaining shares vesting monthly over the following 36 months. The option has an exercise price equal to the closing price of the company’s Class A common stock on the grant date and a ten-year term. This grant was made under the company's 2026 Employment Inducement Equity Incentive Plan.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Contineum Therapeutics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260128919609) on January 28, 2026, and is solely responsible for the information contained therein.